ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 53 filers reported holding ATOSSA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,857 | -15.3% | 36,466 | +44.8% | 0.00% | – |
| Q2 2023 | $31,724 | +56.2% | 25,178 | -34.5% | 0.00% | -100.0% |
| Q4 2022 | $20,309 | -36.5% | 38,428 | +1.0% | 0.00% | 0.0% |
| Q3 2022 | $32,000 | +128.6% | 38,038 | +198.2% | 0.00% | – |
| Q2 2022 | $14,000 | +7.7% | 12,755 | +2.3% | 0.00% | – |
| Q4 2018 | $13,000 | – | 12,474 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 65,714 | $47,636 | 0.04% |
| Laurion Capital Management LP | 2,225,800 | $1,613,482 | 0.01% |
| ETF MANAGERS GROUP, LLC | 42,442 | $30,766 | 0.00% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 50,000 | $36,245 | 0.00% |
| Renaissance Technologies | 936,070 | $679 | 0.00% |
| Caption Management, LLC | 75,000 | $54,368 | 0.00% |
| St. Johns Investment Management Company, LLC | 1,550 | $1,124 | 0.00% |
| J. L. Bainbridge & Co., Inc. | 10,621 | $7,699 | 0.00% |
| D. E. Shaw & Co., Inc. | 823,362 | $596,855 | 0.00% |
| WELLS FARGO & COMPANY/MN | 5,023 | $3,642 | 0.00% |